What To Look For From SGRY

Healthcare company Surgery Partners (NASDAQ:SGRY) will be announcing earnings results this Monday before market open. Here’s what to expect.

Surgery Partners beat analysts’ revenue expectations by 1.2% last quarter, reporting revenues of $826.2 million, up 8.4% year on year. It was a very strong quarter for the company, with a solid beat of analysts’ sales volume estimates and a beat of analysts’ EPS estimates.

Is Surgery Partners a buy or sell going into earnings? Read our full analysis here, it’s free for active Edge members.

This quarter, analysts are expecting Surgery Partners’s revenue to grow 6.7% year on year to $821.8 million, slowing from the 14.3% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $0.16 per share.

Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Surgery Partners has missed Wall Street’s revenue estimates three times over the last two years.

Looking at Surgery Partners’s peers in the outpatient & specialty care segment, some have already reported their Q3 results, giving us a hint as to what we can expect. Select Medical delivered year-on-year revenue growth of 7.2%, beating analysts’ expectations by 2.7%, and U.S. Physical Therapy reported revenues up 17.3%, topping estimates by 1%. Select Medical traded down 2.7% following the results while U.S. Physical Therapy was also down 12.1%.

Read our full analysis of Select Medical’s results here and U.S. Physical Therapy’s results here.

There has been positive sentiment among investors in the outpatient & specialty care segment, with share prices up 3.9% on average over the last month. Surgery Partners is up 11.1% during the same time and is heading into earnings with an average analyst price target of $30.82 (compared to the current share price of $21.93).

P.S. STOP buying the AI stocks everyone’s talking about. The real money? It’s in the profitable pick nobody’s watching yet. We’ve identified an AI profit machine that’s flying under Wall Street’s radar—for now. We can’t keep this research public forever—grab your FREE copy before we pull it offline. GO HERE NOW.

StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.